NCT03389802 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03389802
Title	Phase I Study of APX005M in Pediatric CNS Tumors
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Pediatric Brain Tumor Consortium
Indications	central nervous system cancer brain stem glioma
Therapies	Sotigalimab
Age Groups:	adult \| child
Covered Countries	USA

Filter rows:

Showing 1 to 11 of 11 entries

Facility	City	State	Zip	Country	Details
Baylor College of Medicine	Houston	Texas	77030	United States	Details
Children Hospital of Pittsburgh of UPMC	Pittsburgh	Pennsylvania	15224	United States	Details
Children's Healthcare of Atlanta	Atlanta	Georgia	30322	United States	Details
Children's Hospital Colorado	Aurora	Colorado	80045	United States	Details
Children's Hospital Los Angeles	Los Angeles	California	90026	United States	Details
Childrens National Medical Center	Washington	District of Columbia	20010-2970	United States	Details
Cincinnati Children Hospital Medical Center	Cincinnati	Ohio	45229	United States	Details
Lucile Packard Children Hospital Stanford University	Palo Alto	California	94304	United States	Details
Lurie Childrens Hospital-Chicago	Chicago	Illinois	60614	United States	Details
Memorial Sloan Kettering Cancer Center	New York	New York	10065	United States	Details
St. Jude Children Research Hospital	Memphis	Tennessee	38105	United States	Details

Showing 1 to 11 of 11 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT03389802Clinical Trial Detail